Panel Discussion: How Do We Move Molecular Glues from Serendipity to Strategy While Overcoming Discovery Challenges?

• From serendipity to platforms: Transitioning molecular glues from accidental findings to systematic discovery pipelines with scalable screening and validation strategies
• Beyond degradation: Exploring non-degrading molecular glues that stabilize or reprogram protein-protein interactions to modulate function
• Therapeutic reach: Applying molecular glues across oncology, immunology and neurology to leverage context-specific mechanisms and previously intractable targets

Speakers:

SCOTT EDMONDSON

SVP Chemistry

Nimbus Therapeutics

Stephane Peluso

EIR

Sant Ventures

Peggy Thompson

Senior Vice President, Head of Biology

Plexium Inc.

Roland Hjerpe

Senior Principal Scientist

Sygnature Discovery